Racial/Ethnic Disparities in Arteriovenous Fistula Use

This article originally appeared here.
Share this content:
Racial/Ethnic Disparities in Arteriovenous Fistula Use
Racial/Ethnic Disparities in Arteriovenous Fistula Use

THURSDAY, April 30, 2015 (HealthDay News) -- Black and Hispanic patients are significantly less likely to initiate hemodialysis with arteriovenous fistula (AVF), compared with white patients, according to a study published online April 29 in JAMA Surgery.

Devin S. Zarkowsky, M.D., from the Dartmouth-Hitchcock Medical Center in Lebanon, N.H., and colleagues conducted a retrospective analysis of 396,075 patients with end-stage renal disease in the U.S. Renal Data System, who started hemodialysis from 2006 through 2010. The authors assessed utilization of AVF, arteriovenous graft, and intravascular hemodialysis catheter.

The researchers found that more white patients initiated hemodialysis with an AVF than black patients or Hispanic patients (18.3 versus 15.5 and 14.6 percent, respectively; P < 0.001). Despite being younger and having less coronary artery disease, chronic obstructive pulmonary disease, and cancer than white patients with an AVF, black patients less frequently initiated hemodialysis with an AVF. In analyses stratified by medical insurance status, initiation of hemodialysis with an AVF was less frequent for black patients (odds ratios, 0.90 for uninsured and 0.85 for insured) and Hispanic patients (odds ratios, 0.72 for uninsured and 0.81 for insured) compared with white patients (P < 0.05 for all).

"The sociocultural underpinnings of these disparities deserve investigation and redress to maximize the benefits of initiating hemodialysis via fistula in patients with end-stage renal disease irrespective of race/ethnicity," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »